In-Vitro and In-Vivo Study of Fluorouracil Loaded Solid Lipid Nanoparticle in The Treatment of Skin Cancer

Authors

  • Bhavik Sharma
  • Amit Bhargava

Keywords:

Fluorouracil, In-vitro and In-vivo

Abstract

The cancer medicine Fluorouracil functions as an antimetabolite for widespread clinical treatment of various cancers. A systemic administration of the drug causes strong adverse reactions which negatively affect its medical efficacy. A study of topical delivery methods emerged to solve the current problems in skin cancer treatments. The therapeutic benefits of this technique are limited because the drug struggles to penetrate through the skin barrier. The researchers developed Fluorouracil solid lipid nanoparticles into a gel formulation because it improves drug administration by skin along with enhanced therapeutic outcomes and reduced exposure levels in systemic and toxic areas. A research project concentrated on making Fluorouracil dermal penetration more effective through SLN formulation development for skin cancer treatment. The in vitro drug release evaluation incorporated zero order, first order, Higuchi and Korsmeyer-Peppas models to study the release profile but Korsmeyer-Peppas provided the optimal fit that confirmed drug release through a diffusion-controlled mechanism. Laboratory tests analysed acute Fluorouracil-loaded SLN gel toxicities by giving animals treatment amounts from 25 mg/kg to 70 mg/kg. The monitoring of treated animals revealed no mortality or physical abnormalities during a 15-day period. This evidence demonstrates the formulated product is secure for use.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Chow, K. T., Chan, L. W. and Heng, P. W. S. (2008). Characterization of spreadability of nonaqueous ethylcellulose gel matrices using dynamic contact angle. J Pharm Sci 97: 3467–82.

Cirri, M., Bragagni, M., Mennini, N. and Mura, P. (2012). Development of a new delivery system consisting in ‘‘drug–in cyclodextrin–in nanostructured lipid carriers’’ for ketoprofen topical delivery. Eur J Pharm Biopharm 80: 46–53.

De Vringer, T. and De Ronde, H. A. G. (1995). Preparation and structure of a waterin-oil cream containing lipid nanoparticles. J Pharm Sci 84: 466-72.

Garg, D., Aggarwal, S., Garg, A. and Singla, A. K. (2002). Spreading of semisolid formulations. Pharm Technol 26: 84–95.

Hasanovic, A., Winkler, R., Resch, G. P. and Valenta, C. (2011). Modification of the conformational skin structure by treatment with liposomal formulations and its correlation to the penetration depth of aciclovir. Eur J Pharm Biopharm 79: 76- 81.

Karande, P. and Mitragotri, S. (2009). Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta 1788: 2362–373.

Kakadia, P.G. and Conway, B.R., 2014. Solid lipid nanoparticles: a potential approach for dermal drug delivery. American Journal of Pharmacological Sciences, 2(5A).

Ekambaram, P., Sathali, A.A.H. and Priyanka, K., 2012. Solid lipid nanoparticles: a review. Sci Rev Chem Commun, 2(1), pp.80-102.

Sonawane, R., Harde, H., Katariya, M., Agrawal, S. and Jain, S., 2014. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert opinion on drug delivery, 11(12), pp.1833-1847.

Chen-yu, G., Chun-fen, Y., Qi-lu, L., Qi, T., Yan-wei, X., Wei-na, L., Guang-xi, Z. (2012). Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm 430: 292–98.

Chow, K. T., Chan, L. W. and Heng, P. W. S. (2008). Characterization of spreadability of nonaqueous ethylcellulose gel matrices using dynamic contact angle. J Pharm Sci 97: 3467–82.

Cirri, M., Bragagni, M., Mennini, N. and Mura, P. (2012). Development of a new delivery system consisting in ‘‘drug–in cyclodextrin–in nanostructured lipid carriers’’ for ketoprofen topical delivery. Eur J Pharm Biopharm 80: 46–53.

Cohen-Avrahami, M., Libster, D., Aserin, A. and Garti, N. (2012). Penetratininduced transdermal delivery from HII mesophases of sodium diclofenac. J Control Release 159: 419–28.

Cui, Z., Hsu, C. H. and Mumper, R. J. (2003). Physical characterization and macrophage cell uptake of mannan-coated nanoparticles. Drug Dev Ind Pharm 29: 689–700.

Curry, S. L., Cogar, S. M. and Cook, J. L. (2005). Non-steroidal anti-inflammatory drugs: a review. J Am Animal Hosp Assoc 41: 298–09.

Downloads

Published

2025-05-13

How to Cite

1.
Sharma B, Bhargava A. In-Vitro and In-Vivo Study of Fluorouracil Loaded Solid Lipid Nanoparticle in The Treatment of Skin Cancer. J Neonatal Surg [Internet]. 2025May13 [cited 2025Sep.25];14(21S):1372-80. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/5720